Clinical Trial

Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®

Study acronym: ECH2O2
Recruiting
View on ClinicalTrials.gov →
Summary
This study will evaluate hiatal hernia recurrence rate and post-operative complications following the use of OviTex Core Resorbable or OviTex 1S Resorbable.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-07-14; most recent amendment 2026-02-05.
Status change: Not Yet Recruiting → Recruiting 2025-08-04
Trial Details
NCT Number NCT07070115
Lead Sponsor Tela Bio Inc
Conditions Hiatal Hernia
Enrollment 173 participants
Start Date 2025-07-25
Primary Completion 2031-12-31 (estimated)
Study Completion 2032-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-09